Video wird geladen...
Video konnte nicht geladen werden
Chinese scientists have developed the world’s first iPSC-derived allogeneic cell therapy for drug-resistant epilepsy to win both China NMPA and US FDA clinical trial approvals. Unlike conventional drugs that mainly suppress symptoms, this therapy directly targets the damaged neurons at the root of seizures, repairs neural circuits, and aims... show more
12,921 Aufrufe • vor 3 Monaten •via X (Twitter)
0 Kommentare
Keine Kommentare verfügbar
Kommentare vom Original-Post werden hier angezeigt
